Proprietary Research Databases
| PAD Projected by Diabetes Method | PAD by Age & Glucose Status | 2010-2030 |
|---|---|---|
| CLI Projected by Diabetes Method | CLI by PAD, Age & Glucose Status | 2010-2030 |
| PAD by Disease Severity | IC, CLI, Asymptomatic | 2010-2030 |
| PAD Percent Diagnosed & Treated | Historic Projected | 1997-2010* 2010-2030 |
| CLI by Rutherford Category | Rutherford 4, Rutherford 5, Rutherford 6 | 2010-2030 |
| CLI Treatment Pathways | Revascularization, Amputation, Palliative | 2010-2030 |
| CLI Treatment Pathways by Rutherford Category | Revascularization, Amputation, Palliative | 2010-2030 |
| IC Treatment Pathways | Revascularization, Amputation, Exercise, Drug, None | 2010-2030 |
| PAD Interventional Market | Endovascular, Surgical Bypass, Amputation | 1997-2010* 2010-2030 |
| PAD Interventional Market by Vascular Territory | Aortoiliac, Femoropopliteal, Tibioperoneal | 1997-2010* 2010-2030 |
| PAD Analysis of Angioplasty & Atherectomy | Number of Procedures, Dollar value | 2003-2010 |
| Hospital Discharges by Disease Severity | IC, CLI | 1997-2010* |
| Hospital Costs (Charges) by Disease Severity | IC, CLI | 1997-2010* |
*Most recent year available